Revolutionizing Therapy for ALS and Alzheimer’s with Coya Therapeutics’ Howard Berman and Daniel Barvin

Chris interviews the leaders of Coya Therapeutics, a pharmaceutical company based in Houston revolutionizing the push for effective neurodegenerative disease therapies. Coya went public with only five team members after working with world-renowned researcher and neurologist Stanley Appel to commercialize new therapies for neurological diseases in order to make them publically available. Dr. Howard Berman, the Founder and CEO of Coya, and Daniel Barvin, the Vice President of Operations and Patient Advocacy share the background of the company and where it’s heading.